跳至主要内容
临床试验/NCT00232219
NCT00232219已完成4 期

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.

Melbourne Health1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2003年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
200
试验地点
1
主要终点
Recurrence of atrial fibrillation followed cardioversion

研究概览

简要总结

The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion.

Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion.

Cardioversion involves resetting the heart back to normal with the use of electric current.

There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion.

Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with persistent Atrial Fibrillation on Warfarin.

排除标准

  • paroxysmal atrial fibrillation with self terminating episodes.
  • left atrial size>6.0cm
  • myocardial infarction in the previous 6 months.
  • contraindications to amiodarone use .
  • cardiac surgery in the previous 3 months .
  • an acute reversible illness contributing to the development of af
  • a QTc interval > 480ms.
  • pregnancy

研究组 & 干预措施

Fish oil

Experimental

Patients given 6g/day of fish oil containing 1.8g/d of EPA+DHA in a 1.5:1 ratio.

干预措施: Fish oil (Drug)

结局指标

主要结局

Recurrence of atrial fibrillation followed cardioversion

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验